A microRNA-135a/b binding polymorphism in CD133 confers decreased risk and favorable prognosis of lung cancer in Chinese by reducing CD133
发布时间：2019-05-10 分享到：
MassArray (Sequenom, San Diego, CA) was used for genotyping the 13 SNPs in the discovery set using allele-specific matrix-assisted laser desorption–time of flight mass spectrometry by commercial company (Biomiao Biological Technology, Beijing, China). Then the promising SNPs were further genotyped in the validation sets with MassArray (Sequenom).
上一篇：Genetic variability of ERCC1 and ERCC2 influences treatment outcomes in gastric cancer
下一篇：Promoter methylation of fas apoptotic inhibitory molecule 2 gene is associated with obesity and dyslipidaemia in Chinese children
返回列表
相关推荐
- Increased osteogenesis in osteoporotic bone marrow stromal cells by ove2019-05-13
- Targeted P2X7R shRNA delivery attenuates sympathetic nerve sprouting an2019-05-13
- TNF-a (-238G/A and -308G/A) gene polymorphisms may not contribute to t2019-05-13
- Genetic polymorphisms in Sox17 associated with intracranial aneurysm in2019-05-13
- Association of ENAM, TUFT1, MMP13, IL1B, IL10 and IL1RN gene poly2019-05-13
- miR-509-3p enhances platinum drug sensitivity in ovarian cancer2019-05-13